Welcome to our dedicated page for REALLOYS news (Ticker: ALOY), a resource for investors and traders seeking the latest updates and insights on REALLOYS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect REALLOYS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of REALLOYS's position in the market.
REalloys (NASDAQ: ALOY) closed an upsized underwritten public offering of 2,702,702 shares of common stock at $18.50 per share on March 9, 2026, producing gross proceeds of approximately $50 million before fees. The underwriters have a 30-day option for an additional 396,963 shares.
Clear Street led the deal with Needham as joint book-runner; net proceeds are intended for working capital and general corporate purposes. The offering was made from an effective Form S-3 shelf registration.
REalloys (NASDAQ: ALOY) priced an upsized underwritten public offering of 2,702,702 shares at $18.50 per share and granted underwriters a 30-day option for up to 396,963 additional shares. The offering is expected to close on or about March 9, 2026.
The gross proceeds are expected to be approximately $50 million before underwriting discounts and expenses. The company expects to use net proceeds for working capital and general corporate purposes. The offering is made under a shelf registration on Form S-3 (File No. 333-284626).
REalloys (NASDAQ: ALOY) intends to sell shares of its common stock in an underwritten public offering, with underwriters having a 30-day option to purchase additional shares. The company expects to use net proceeds for working capital and general corporate purposes. The offering is subject to market conditions and will be made from an effective Form S-3 shelf registration.
Clear Street is lead book-running manager and Needham & Company is joint book-running manager. A preliminary prospectus supplement will be filed with the SEC.
REalloys (NASDAQ: ALOY) received a Defense Logistics Agency contract under topic DLA212-004 to scale metallothermal production of samarium (Sm) and gadolinium (Gd).
The award funds engineering design for a 300 ton/year modular production facility, supports a provisional patent for REalloys’ zero-waste metallization, and targets up to 50% lower production costs via direct reduction of SEG feedstocks.